2021-01-11,Is the Options Market Predicting a Spike in PhaseBio (PHAS) Stock?
2020-11-30,Is PhaseBio Pharmaceuticals (PHAS) A Good Stock To Buy Now?
2020-11-16,"Earnings Update: PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) Just Reported And Analysts Are Trimming Their Forecasts"
2020-11-12,PhaseBio Reports Recent Business Highlights and Third-Quarter 2020 Financial Results
2020-11-11,PhaseBio to Present at the Stifel 2020 Virtual Healthcare Conference on November 18th
2020-10-26,PhaseBio Plunges 10% As Covid-19 Trial Called Off; Street Stays Bullish
2020-10-23,PhaseBio Provides Pemziviptadil (PB1046) Program Update
2020-10-12,"What Kind Of Investors Own Most Of PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS)?"
2020-10-06,PhaseBio Doses First Patients in Canada as Part of the REVERSE-IT Global Phase 3 Trial of Bentracimab for Reversal of the Antiplatelet Effects of Ticagrelor
2020-09-09,PhaseBio to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
2020-08-11,"PHASEBIO PHARMA (PHAS) Reports Q2 Loss, Lags Revenue Estimates"
2020-08-11,PhaseBio Reports Recent Business Highlights and Second-Quarter 2020 Financial Results
2020-08-04,Analysts Estimate PHASEBIO PHARMA (PHAS) to Report a Decline in Earnings: What to Look Out for
2020-08-03,PhaseBio to Present at the William Blair Biotech Focus Conference 2020
2020-07-20,PhaseBio Initiates Phase II Study for Coronavirus Patients
2020-07-17,"The Daily Biotech Pulse: 2 IPOs, Nabriva Pneumonia Drug Gets Canadian Regulatory Nod, PhaseBio Doses First COVID-19 Trial Patient"
2020-07-16,PhaseBio Doses First Patient in VANGARD Phase 2 Clinical Trial to Evaluate PB1046 for Hospitalized COVID-19 Patients
2020-07-12,"What You Need To Know About The PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) Analyst Downgrade Today"
2020-07-06,3 Coronavirus Penny Stocks With Triple-Digit Upside Potential
2020-06-15,"Hedge Funds Are Selling PhaseBio Pharmaceuticals, Inc. (PHAS)"
2020-06-03,"Biotech Stock Roundup: GILD's Coronavirus Drug Update, NTLA-REGN Deal & More"
2020-05-28,PhaseBio Gets FDA Nod to Begin Study for Coronavirus Treatment
2020-05-28,P/E Ratio Insights for PhaseBio Pharmaceuticals
2020-05-28,PhaseBio Cleared by FDA for Trial of Virus Treatment
2020-05-28,"The Daily Biotech Pulse: PhaseBio To Start Potential Pivotal COVID-19 Trial, Immunomedics CEO Quits, Tetraphase Receives Sweetened Offer"
2020-05-28,PhaseBio Explodes 82% After-Hours On FDA Nod For Covid-19 Clinical Trial
2020-05-27,PhaseBio Launches Clinical Trial to Evaluate PB1046 as a Treatment for Hospitalized COVID-19 Patients
2020-05-12,"PHASEBIO PHARMA (PHAS) Reports Q1 Loss, Lags Revenue Estimates"
2020-05-12,PhaseBio Reports First Quarter 2020 Financial Results and Recent Business Highlights
2020-05-07,Analysts Estimate PHASEBIO PHARMA (PHAS) to Report a Decline in Earnings: What to Look Out for
2020-04-23,"PhaseBio Pharmaceuticals, Inc. (PHAS) Shares March Higher, Can It Continue?"
2020-04-14,"Easy Come, Easy Go: How PhaseBio Pharmaceuticals (NASDAQ:PHAS) Shareholders Got Unlucky And Saw 74% Of Their Cash Evaporate"
2020-03-30,PhaseBio Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Recent Business Highlights
2020-03-17,Analysts Estimate PHASEBIO PHARMA (PHAS) to Report a Decline in Earnings: What to Look Out for
2020-02-26,PhaseBio to Present at Cowen and Company 40th Annual Health Care Conference
2020-02-13,PhaseBio Appoints Alex C. Sapir to Board of Directors
2020-02-11,PhaseBio Announces European Regulatory Update for PB2452
2020-02-06,Wall Street Pros: These 3 Stocks Can Double Next Year
2020-02-05,"The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data"
2020-02-04,PhaseBio Announces Case Study Highlighting PB1046 Hemodynamic Data Presented at the 14th Pulmonary Vascular Research Institute World Congress
2020-01-15,Rock star Growth Puts PhaseBio Pharmaceuticals (NASDAQ:PHAS) In A Position To Use Debt
2020-01-14,"The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug"
2020-01-13,PhaseBio Announces Acquisition of Novel Oral Aldosterone Synthase Inhibitor to Develop for Treatment-Resistant Hypertension
2020-01-10,Shares of Malvern life sciences firm skyrocket on funding deal worth up to $120M
2020-01-10,PhaseBio Announces Financing and Co-Development Collaboration with SFJ Pharmaceuticals® for PB2452
2019-12-19,"Hedge Funds Have Never Been This Bullish On PhaseBio Pharmaceuticals, Inc. (PHAS)"
2019-11-15,PhaseBio to Present at Stifel 2019 Healthcare Conference
2019-11-14,"PHASEBIO PHARMA (PHAS) Reports Q3 Loss, Misses Revenue Estimates"
2019-11-14,PhaseBio Reports Third Quarter 2019 Financial Results and Recent Corporate Progress
2019-11-07,"PhaseBio To Report Third Quarter 2019 Financial Results and Recent Corporate Progress on November 14, 2019"
2019-10-31,"Hedge Funds Have Never Been This Bullish On PhaseBio Pharmaceuticals, Inc. (PHAS)"
2019-10-24,PhaseBio Expands Executive Management Team
2019-10-17,Did You Manage To Avoid PhaseBio Pharmaceuticals's (NASDAQ:PHAS) 21% Share Price Drop?
2019-10-15,PhaseBio Announces First Patient Dosed in Phase 2b Clinical Trial of PB2452 for Reversal of the Antiplatelet Activity of Ticagrelor
2019-10-11,3 Strong Buy Biotech Stocks That Could Triple in 2020
2019-09-26,"A Look At Benzinga Pro's Most-Searched Tickers For September 26, 2019"
2019-09-25,"The Daily Biotech Pulse: PhaseBio Leaps On Trial Results, Pacira Set To Join SmallCap 600 Index, Positive Readout For Amgen's Blood Cancer Drug"
2019-09-24,PhaseBio Announces Completion of Phase 2a Clinical Trial of PB2452 for the Reversal of the Antiplatelet Activity of Ticagrelor
2019-09-03,Pharmacodynamics Evaluation of PhaseBios Novel Ticagrelor Reversal Agent Presented at ESC Congress 2019
2019-08-26,PhaseBio Announces Presentation of PB2452 Data at ESC Congress 2019
2019-08-14,"PhaseBio Announces Receipt of Minutes of End-of-Phase 1 Meeting with the FDA and Alignment on a Single, Non-Randomized Phase 3 Trial to Support BLA Submission for PB2452"
2019-08-13,PhaseBio Reports Second Quarter 2019 Financial Results and Recent Corporate Progress
2019-08-06,"PhaseBio To Report Second Quarter 2019 Financial Results and Recent Corporate Progress on August 13, 2019"
2019-07-19,"Could The PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) Ownership Structure Tell Us Something Useful?"
2019-07-01,PhaseBio Added to Russell 2000® and 3000® Indexes
2019-06-18,"SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating PhaseBio Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors"
2019-06-18,"The Daily Biotech Pulse: PhaseBio Pumped Up, Eiger Exults On Breakthrough Therapy Designation, Biohaven Slips On Stock Sale"
2019-06-17,PhaseBio Announces Positive Preliminary Results from Phase 2a Clinical Trial of PB2452 for the Reversal of the Antiplatelet Activity of Ticagrelor in Older and Elderly Subjects
2019-05-09,PhaseBio Reports First Quarter 2019 Financial Results and Recent Corporate Progress
2019-05-02,"PhaseBio To Report First Quarter 2019 Financial Results and Recent Corporate Progress on May 9, 2019"
2019-04-25,2 Ultra-High Growth Stocks to Buy Now
2019-04-17,PhaseBio completes $49.5M stock sale
2019-04-16,PhaseBio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares
2019-04-16,Billionaires Are Betting This Could Be One Of The Biggest Industries In History
2019-04-12,PhaseBio plans $43M stock sale
2019-04-11,PhaseBio Announces Pricing of Public Offering of Common Stock
2019-04-10,"The Daily Biotech Pulse: Amgen's Bone-Building Osteoporosis Drug Clears FDA Muster, PhaseBio Offering"
2019-04-09,PhaseBio Announces Proposed Public Offering of Common Stock
2019-04-09,Why PhaseBio's stock rose 16 percent Tuesday
2019-04-09,Here's Why PhaseBio Pharmaceuticals Rose as Much as 32.5% Today
2019-04-09,PhaseBio Stock Up on Breakthrough Therapy Status for PB2452
2019-04-09,"The Daily Biotech Pulse: PhaseBio Gets Breakthrough Therapy Designation, FDA Shoots Down Zogenix Epilepsy Regulatory Filing"
2019-04-09,PhaseBio shares soar 28% premarket as FDA speeds path for approval of PB2452
2019-04-09,Dow Jones Futures: Zogenix Leads 3 Big Movers On FDA News
2019-04-08,PhaseBio Receives FDA Breakthrough Therapy Designation for PB2452 for the Reversal of the Antiplatelet Activity of Ticagrelor
2019-04-07,3 Stocks That Have More Than Tripled So Far in 2019
2019-03-26,PhaseBio Reports Fourth Quarter and Full-Year 2018 Financial and Business Results
2019-03-26,"The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Departs"
2019-03-25,PhaseBio Announces Term Loan of up to $15 Million
2019-03-19,PhaseBio Stock Up on Positive Data From PB2452 Phase I Study
2019-03-19,"PhaseBio To Report Fourth Quarter and Full-Year 2018 Financial and Business Results on March 26, 2019"
2019-03-18,PhaseBio's stock more than doubles after positive phase 1 trial results of ticagrelor reversal agent
2019-03-17,Full Results from PhaseBio Phase 1 Clinical Trial of PB2452 Published in the New England Journal of Medicine and Presented at the American College of Cardiologys 68th Annual Scientific Session
2019-03-06,PhaseBio to Present at Cowen and Company 39th Annual Health Care Conference
2019-03-04,PhaseBio Appoints Richard A. van den Broek to Board of Directors
2019-03-04,PhaseBio Announces Acceptance of Late-Breaking Clinical Trial Submission of PB2452 Phase 1 Clinical Trial Results for Presentation at the American College of Cardiologys 68th Annual Scientific Session
2019-01-25,Johnson & Johnson Is Selling These 2 Biotech Stocks
2019-01-10,A few minutes with... PhaseBio CEO Jonathan Mow
2018-12-18,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan"
2018-12-17,PhaseBio Appoints Edmund P. Harrigan to Board of Directors
